To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Commons Chamber - Wed 23 Oct 2019
The National Health Service

"My right hon. Friend was talking about spending on healthcare across the United Kingdom. Scotland has benefited due to increases in healthcare spending in England, but not all the money that comes to Scotland through the Barnett formula has been spent on healthcare. In fact, had spending increases in Scotland …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: The National Health Service
Written Question
Health Professions: Business Interests
Monday 1st April 2019

Asked by: Stephen Kerr (Conservative - Stirling)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the cost to the public purse has been of requiring medical professionals to disclose payments and gifts from medical and other suppliers; and what benefits have been derived from the implementing that requirement.

Answered by Stephen Hammond

There has been no measurement of the cost to the public purse of requiring medical professionals to disclose payments and gifts from medical and other suppliers.

Written Question
Tuberculosis: Health Services
Monday 4th March 2019

Asked by: Stephen Kerr (Conservative - Stirling)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the adequacy of (a) treatment and (b) support for people with with tuberculosis.

Answered by Steve Brine

‘The Collaborative Tuberculosis (TB) Strategy for England 2015 to 2020’ was developed by Public Health England (PHE) in partnership with NHS England and aims to reduce suffering and harm caused by TB through lowering the incidence of the disease in England. The Strategy is available at the following link:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/403231/Collaborative_TB_Strategy_for_England_2015_2020_.pdf

The strategy aims to tackle TB in under-served populations through the commissioning of integrated, multidisciplinary, case management and support for under-served groups. This multidisciplinary support, which may include third sector organisations, should provide targeted outreach interventions, informed by proven models such as ‘Find and Treat’ in London, including specific services for active case finding among homeless people and those attending substance misuse services.

In January 2016, the National Institute for Health and Care Excellence published a clinical guideline that covers preventing, identifying and managing latent and active TB in children, young people and adults. This is available at the following link:

https://www.nice.org.uk/guidance/ng33

In 2017, PHE and the National Health Service issued a ‘TB Service Specification and Clinical Policy’ for use by commissioners and TB services. This builds on the work of the strategy to:

- improve rapid diagnosis and treatment of active TB disease;

- prevention of TB by treating latent infections; and

- focus on complex cases with antimicrobial resistance and patients with other risk factors for poor treatment outcome, such as homelessness.

NHS England is supporting those clinical commissioning groups (CCGs) with the highest burden of disease to provide latent TB testing and treatment programmes which are essential for reducing the incidence of active TB. In 2018/19, the 46 CCGs with the highest burden of disease were supported with £3,594,000 to provide this service.

According to the latest annual report ‘Tuberculosis in England: 2018’ published by PHE, since the peak of TB incidence in England in 2011 the number of people notified with TB had fallen by nearly 40% in 2017. The incidence rate in 2017 was 9.2 per 100,000 population, the lowest recorded rate for England, which for the first time falls under the 10 per 100,000 World Health Organization definition of a low incidence country. The report is available at the following link:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/774091/TB_Annual_Report_2018_2.pdf

Speech in Commons Chamber - Thu 24 Jan 2019
Appropriate ME Treatment

"I could easily say amen and sit down, but I would like to compliment the hon. Member for Glasgow North West (Carol Monaghan) on her speech.

I hope this debate and the passionate interest of colleagues from the across the House bring some encouragement to those suffering from this condition …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: Appropriate ME Treatment
Speech in Westminster Hall - Wed 18 Jul 2018
NHS Whistleblowers

"Just for clarity, I am not advocating bounties. It is one of the options to be looked at, but there are reservations about it, which I know the hon. Lady shares...."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: NHS Whistleblowers
Speech in Westminster Hall - Wed 18 Jul 2018
NHS Whistleblowers

"It is a privilege to serve under your chairmanship, Mr Davies. I congratulate the hon. Member for Central Ayrshire (Dr Whitford) on securing this debate and on her compelling and powerful speech. I find myself agreeing wholeheartedly with what she had to say. It is a noteworthy event when Scottish …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: NHS Whistleblowers
Speech in Westminster Hall - Thu 21 Jun 2018
ME: Treatment and Research

"It is a pleasure to serve under your chairmanship, Mr Rosindell. I pay tribute to the hon. Member for Glasgow North West (Carol Monaghan) for this campaign, which she is doing a superb job of leading. I cannot remember the name of the academic who wrote to her reproaching her …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: ME: Treatment and Research
Speech in Westminster Hall - Thu 21 Jun 2018
ME: Treatment and Research

"I absolutely agree, and I thank the hon. Lady for her intervention.

I cannot speak too highly of Helen Hyland, a constituent of mine, who has done so much to raise awareness of the condition across the UK in her role within the ME Association. She has also done so …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: ME: Treatment and Research
Speech in Commons Chamber - Mon 18 Jun 2018
NHS Long-Term Plan

"I also welcome the statement from the Secretary of State, but I note that it relates to health spending in England only. Will my right hon. Friend spell out what this means for Scotland in particular, thanks to the Barnett consequentials, and how can we ensure that the additional funds …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: NHS Long-Term Plan
Speech in Commons Chamber - Wed 10 Jan 2018
NHS Winter Crisis

"I know that comparing England and Scotland is one of the pastimes that Scottish National party Members like to engage in—it is a fascination for them—but the reality is that in my constituency of Stirling, served by the excellent NHS Forth Valley in Larbert, only 57% of patients were seen …..."
Stephen Kerr - View Speech

View all Stephen Kerr (Con - Stirling) contributions to the debate on: NHS Winter Crisis